Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study

IntroductionIt is not clear whether high mammographic density (MD) is equally associated with all subtypes of breast cancer (BC). We investigated the association between MD and subsequent BC, considering invasiveness, means of detection, pathologic subtype, and the time elapsed since mammographic exploration and BC diagnosis.MethodsBC cases occurring in the population of women who attended screening from 1997 through 2004 in Navarre, a Spanish region with a fully consolidated screening program, were identified via record linkage with the Navarre Cancer Registry (n = 1,172). Information was extracted from the records of their first attendance at screening in that period. For each case, we randomly selected four controls, matched by screening round, year of birth, and place of residence. Cases were classified according to invasiveness (ductal carcinoma in situ (DCIS) versus invasive tumors), pathologic subtype (considering hormonal receptors and HER2), and type of diagnosis (screen-detected versus interval cases). MD was evaluated by a single, experienced radiologist by using a semiquantitative scale. Data on BC risk factors were obtained by the screening program in the corresponding round. The association between MD and tumor subtype was assessed by using conditional logistic regression.ResultsMD was clearly associated with subsequent BC. The odds ratio (OR) for the highest MD category (MD >75%) compared with the reference category (MD <10%) was similar for DCIS (OR = 3.47; 95% CI = 1.46 to 8.27) and invasive tumors (OR = 2.95; 95% CI = 2.01 to 4.35). The excess risk was particularly high for interval cases (OR = 7.72; 95% CI = 4.02 to 14.81) in comparison with screened detected tumors (OR = 2.17; 95% CI = 1.40 to 3.36). Sensitivity analyses excluding interval cases diagnosed in the first year after MD assessment or immediately after an early recall to screening yielded similar results. No differences were seen regarding pathologic subtypes. The excess risk associated with MD persisted for at least 7 to 8 years after mammographic exploration.ConclusionsOur results confirm that MD is an important risk factor for all types of breast cancer. High breast density strongly increases the risk of developing an interval tumor, and this excess risk is not completely explained by a possible masking effect.

[1]  Sarah A. Edwards,et al.  Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. , 2011, Journal of the National Cancer Institute.

[2]  N. Ascunce,et al.  Programa de detección precoz de cáncer de mama: Resultados de proceso e indicadores de impacto (1990-2002) , 2004 .

[3]  N. Ascunce,et al.  [Breast cancer screening program. Results of the process and impact indicators (1990-2002)]. , 2004, Anales del sistema sanitario de Navarra.

[4]  N. Boyd,et al.  Mammographic density and breast cancer risk: current understanding and future prospects , 2011, Breast Cancer Research.

[5]  I. Vejborg,et al.  Breast density and outcome of mammography screening: a cohort study , 2009, British Journal of Cancer.

[6]  S. Cummings,et al.  Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness , 2011, Annals of Internal Medicine.

[7]  N. Ascunce,et al.  Cancer screening in Spain. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  L. Kolonel,et al.  Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. , 2011, Cancer epidemiology.

[9]  W. Willett,et al.  Body size across the life course, mammographic density, and risk of breast cancer. , 2011, American journal of epidemiology.

[10]  Anna Chiarelli,et al.  Body Size, Mammographic Density, and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[11]  Diederick E Grobbee,et al.  Postmenopausal hormone therapy and changes in mammographic density. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Peris,et al.  Alcohol, tobacco, and mammographic density: a population-based study , 2011, Breast Cancer Research and Treatment.

[13]  P. Porter,et al.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.

[14]  Consumer Protection,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  S. Cummings,et al.  Mammographic density and estrogen receptor status of breast cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Rongwei Fu,et al.  Risk Factors for Breast Cancer for Women Aged 40 to 49 Years , 2012, Annals of Internal Medicine.

[17]  I. Vejborg,et al.  Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark. , 2011, Cancer epidemiology.

[18]  Les Irwig,et al.  Radiological surveillance of interval breast cancers in screening programmes. , 2006, The Lancet. Oncology.

[19]  Kevin W. Eliceiri,et al.  Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage , 2009, Oncogene.

[20]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.

[21]  N. Ascunce,et al.  ARTÍCULOS ORIGINALES Programa de detección precoz de cáncer de mama. Resultados de proceso e indicadores de impacto (1990-2002) Breast Cancer Screening Program. Results of the process and impact indicators (1990-2002) , 2004 .

[22]  N. Schork,et al.  The Relative Importance of Genetics and Environment on Mammographic Density , 2009, Cancer Epidemiology Biomarkers & Prevention.

[23]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[24]  Douglas Easton,et al.  Mammographic Density, Estrogen Receptor Status and Other Breast Cancer Tumor Characteristics , 2010, The breast journal.

[25]  M. Peris,et al.  Adult weight gain, fat distribution and mammographic density in Spanish pre- and post-menopausal women (DDM-Spain) , 2012, Breast Cancer Research and Treatment.

[26]  M. Peris,et al.  Obstetric history and mammographic density: a population-based cross-sectional study in Spain (DDM-Spain) , 2012, Breast Cancer Research and Treatment.

[27]  K. Kerlikowske,et al.  Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. , 2012, Annals of epidemiology.

[28]  M. Pollán,et al.  Breast cancer incidence in Spain before, during and after the implementation of screening programmes. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  R. J. Marshall,et al.  Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. , 1985, Statistics in medicine.

[30]  Jack Cuzick,et al.  Clinical and epidemiological issues in mammographic density , 2012, Nature Reviews Clinical Oncology.

[31]  N. Boyd,et al.  Mammographic density and risk of breast cancer. , 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[32]  S. Mook,et al.  Independent prognostic value of screen detection in invasive breast cancer. , 2011, Journal of the National Cancer Institute.

[33]  P. Gøtzsche,et al.  Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. , 2011, The Lancet. Oncology.

[34]  Ellen Warner,et al.  Clinical practice. Breast-cancer screening. , 2011, The New England journal of medicine.

[35]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[36]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[37]  P. Porter,et al.  Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. , 1999, Journal of the National Cancer Institute.

[38]  A. Wolk,et al.  Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis , 2009, International journal of cancer.

[39]  L. Bernstein,et al.  Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer , 2009, Cancer Epidemiology, Biomarkers and Prevention.

[40]  X. Castells,et al.  Effect of false-positives and women’s characteristics on long-term adherence to breast cancer screening , 2011, Breast Cancer Research and Treatment.

[41]  Bernard Rosner,et al.  Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. , 2011, Journal of the National Cancer Institute.